Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.
Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B, De Cecco L, Fasano E, Bianchi F, Bertolotti A, Tripodo C, Villani L, Corsi F, Guglielmetti S, Balsari A, Triulzi T, Tagliabue E. Di Modica M, et al. Among authors: villani l. Cancer Res. 2021 Apr 15;81(8):2195-2206. doi: 10.1158/0008-5472.CAN-20-1659. Epub 2021 Jan 22. Cancer Res. 2021. PMID: 33483370 Free article.
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2.
Gennari R, Menard S, Fagnoni F, Ponchio L, Scelsi M, Tagliabue E, Castiglioni F, Villani L, Magalotti C, Gibelli N, Oliviero B, Ballardini B, Da Prada G, Zambelli A, Costa A. Gennari R, et al. Among authors: villani l. Clin Cancer Res. 2004 Sep 1;10(17):5650-5. doi: 10.1158/1078-0432.CCR-04-0225. Clin Cancer Res. 2004. PMID: 15355889
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2.
Varchetta S, Gibelli N, Oliviero B, Nardini E, Gennari R, Gatti G, Silva LS, Villani L, Tagliabue E, Ménard S, Costa A, Fagnoni FF. Varchetta S, et al. Among authors: villani l. Cancer Res. 2007 Dec 15;67(24):11991-9. doi: 10.1158/0008-5472.CAN-07-2068. Cancer Res. 2007. PMID: 18089830 Clinical Trial.
Ultrastructural analysis of breast cancer patient-derived organoids.
Signati L, Allevi R, Piccotti F, Albasini S, Villani L, Sevieri M, Bonizzi A, Corsi F, Mazzucchelli S. Signati L, et al. Among authors: villani l. Cancer Cell Int. 2021 Aug 10;21(1):423. doi: 10.1186/s12935-021-02135-z. Cancer Cell Int. 2021. PMID: 34376194 Free PMC article.
Raman Spectroscopy Reveals That Biochemical Composition of Breast Microcalcifications Correlates with Histopathologic Features.
Vanna R, Morasso C, Marcinnò B, Piccotti F, Torti E, Altamura D, Albasini S, Agozzino M, Villani L, Sorrentino L, Bunk O, Leporati F, Giannini C, Corsi F. Vanna R, et al. Among authors: villani l. Cancer Res. 2020 Apr 15;80(8):1762-1772. doi: 10.1158/0008-5472.CAN-19-3204. Epub 2020 Feb 24. Cancer Res. 2020. PMID: 32094303 Free article.
Raman analysis of microcalcifications in male breast cancer.
Caldarone A, Piccotti F, Morasso C, Truffi M, Sottotetti F, Guerra C, Albasini S, Agozzino M, Villani L, Corsi F. Caldarone A, et al. Among authors: villani l. Spectrochim Acta A Mol Biomol Spectrosc. 2021 Dec 15;263:120185. doi: 10.1016/j.saa.2021.120185. Epub 2021 Jul 15. Spectrochim Acta A Mol Biomol Spectrosc. 2021. PMID: 34298281 Free article. Review.
Involved margins after lumpectomy for breast cancer: Always to be re-excised?
Sorrentino L, Agozzino M, Albasini S, Bossi D, Mazzucchelli S, Vanna R, Papadopoulou O, Villani L, Corsi F. Sorrentino L, et al. Among authors: villani l. Surg Oncol. 2019 Sep;30:141-146. doi: 10.1016/j.suronc.2019.08.002. Epub 2019 Aug 6. Surg Oncol. 2019. PMID: 31500779 Free article.
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
Regan MM, Pagani O, Francis PA, Fleming GF, Walley BA, Kammler R, Dell'Orto P, Russo L, Szőke J, Doimi F, Villani L, Pizzolitto S, Öhlschlegel C, Sessa F, Peg Cámara V, Rodríguez Peralto JL, MacGrogan G, Colleoni M, Goldhirsch A, Price KN, Coates AS, Gelber RD, Viale G; SOFT and TEXT Investigators and International Breast Cancer Study Group. Regan MM, et al. Among authors: villani l. Breast Cancer Res Treat. 2015 Nov;154(2):275-86. doi: 10.1007/s10549-015-3612-z. Epub 2015 Oct 22. Breast Cancer Res Treat. 2015. PMID: 26493064 Free PMC article.
301 results